USPTO 2015–2025 USPTO PatentsView US Corporation

Contrafect Corporation

USPTO PatentsView assignee record - 16 granted patents across 10 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

16
Total patents granted
10
CPC technology areas
22.1
Avg claims per patent
+120%
5-year filing velocity

The verdict

Contrafect holds 16 US patents across 10 technology areas, rank #17,550 of 50,000 tracked assignees.

#17,550
of 50,000 US assignees by volume
Top 31%
by Innovation Score (42.2/100)
22.1
avg claims per patent
+120%
filing velocity, last 5 yrs

Portfolio overview

Contrafect Corporation has been granted 16 US utility patents between 2015 and 2023, placing Contrafect Corporation at rank #17,550 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.1 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Contrafect Corporation is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 42.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 11 grants, compared with 5 in the 2015–2019 window, a +120% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Contrafect Corporation's 22.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Contrafect Corporation against peers pursuing similar technology classes.

How does Contrafect compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows Contrafect holds 16 patents, placing it at rank #17,550 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Contrafect's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

012345 20152016201720182020202120222023 2
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Contrafect Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 6.3%
2016 1 6.3%
2017 2 12.5%
2018 1 6.3%
2020 4 25.0%
2021 1 6.3%
2022 4 25.0%
2023 2 12.5%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Accelerating

Where it ranks

Overall rank by patents

#17,550

Across all tracked assignees

Innovation Score

42.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Contrafect Corporation hold?
Contrafect Corporation holds 16 US granted patents filed between 2015 and 2023, spanning 10 technology areas.
What is Contrafect Corporation's Innovation Score?
Contrafect Corporation has an Innovation Score of 42.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Contrafect Corporation focus on?
Contrafect Corporation's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 15 patents. The company has filed patents in 10 CPC subclasses total.
Is Contrafect Corporation's patent filing rate increasing or decreasing?
Contrafect Corporation's recent filing velocity is +120% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Contrafect Corporation's patents?
Contrafect Corporation's patents average 22.1 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Contrafect Corporation patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How to use this portfolio

Contrafect's 16 grants land it in the top 31% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Contrafect ranks #17,550 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.